SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-10-11 18:13
Tx date 2021-10-05 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-40,244.75
-152,500 vol
$0.2639 each 		5,513,500
Filed 2021-10-11 18:12
Tx date 2021-10-10 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-31,989.80
-118,000 vol
$0.2711 each 		5,395,500
Filed 2021-10-11 18:10
Tx date 2021-09-17 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,820
-24,500 vol
$0.36 each 		5,666,000
Filed 2021-10-06 11:32
Tx date 2021-08-20 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-54,778.80
-119,500 vol
$0.4584 each 		5,690,500
Filed 2021-10-06 11:31
Tx date 2021-08-16 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,657.50
-32,500 vol
$0.451 each 		5,810,000
Filed 2021-10-06 11:29
Tx date 2021-08-11 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-12,457.80
-27,000 vol
$0.4614 each 		5,842,500
Filed 2021-10-06 11:27
Tx date 2021-08-10 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,377.30
-30,500 vol
$0.4386 each 		5,869,500
Filed 2021-07-27 02:50
Tx date 2016-12-30 		$CLAS
Claritas Pharmaceuticals, Inc. 		Salzman, Andrew
6 - Director or Senior Officer of 10% Security Holder
Holder: Salzman Group, Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		5,900,000
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+3,180,699 vol 		3,927,401
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+746,702 vol 		746,702